Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 20

1.

E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.

L'Huillier AG, Abed Y, Petty TJ, Cordey S, Thomas Y, Bouhy X, Schibler M, Simon A, Chalandon Y, van Delden C, Zdobnov E, Boquete-Suter P, Boivin G, Kaiser L.

J Infect Dis. 2015 Dec 1;212(11):1726-34. doi: 10.1093/infdis/jiv288. Epub 2015 May 17.

PMID:
25985905
2.

Genome rearrangement of influenza virus for anti-viral drug screening.

Sutton TC, Obadan A, Lavigne J, Chen H, Li W, Perez DR.

Virus Res. 2014 Aug 30;189:14-23. doi: 10.1016/j.virusres.2014.05.003. Epub 2014 May 12.

3.

A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.

Oh DY, Hurt AC.

Scientifica (Cairo). 2014;2014:430629. doi: 10.1155/2014/430629. Epub 2014 Apr 2. Review.

4.

Airborne transmission of highly pathogenic H7N1 influenza virus in ferrets.

Sutton TC, Finch C, Shao H, Angel M, Chen H, Capua I, Cattoli G, Monne I, Perez DR.

J Virol. 2014 Jun;88(12):6623-35. doi: 10.1128/JVI.02765-13. Epub 2014 Apr 2.

5.

Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach.

Petridis D, Zarogoulidis P, Kallianos A, Kioumis I, Trakada G, Spyratos D, Papaiwannou A, Porpodis K, Huang H, Rapti A, Hohenforst-Schmidt W, Zarogoulidis K.

Ther Clin Risk Manag. 2014 Feb 7;10:77-86. doi: 10.2147/TCRM.S57429. eCollection 2014.

6.

Determination of neuraminidase kinetic constants using whole influenza virus preparations and correction for spectroscopic interference by a fluorogenic substrate.

Marathe BM, Lévêque V, Klumpp K, Webster RG, Govorkova EA.

PLoS One. 2013 Aug 15;8(8):e71401. doi: 10.1371/journal.pone.0071401. eCollection 2013.

7.

Continued dominance of pandemic A(H1N1) 2009 influenza in Victoria, Australia in 2010.

Grant K, Franklin L, Kaczmarek M, Hurt A, Kostecki R, Kelly H, Fielding J.

Western Pac Surveill Response J. 2011 Aug 31;2(3):10-8. doi: 10.5365/WPSAR.2011.2.2.009. Print 2011 Jul.

8.

Oseltamivir-resistant influenza A(H1N1)pdm09 virus in southern Brazil.

Marx C, Gregianini TS, Lehmann FK, Lunge VR, Carli Sd, Dambrós BP, Tumioto GL, Seadi C, Fonseca AS, Ikuta N.

Mem Inst Oswaldo Cruz. 2013 May;108(3). pii: S0074-02762013000300392. doi: 10.1590/S0074-02762013000300021.

9.

Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses.

Pollara CP, Piccinelli G, Rossi G, Cattaneo C, Perandin F, Corbellini S, Tomasi DD, Bonfanti C.

BMC Infect Dis. 2013 Mar 7;13:127. doi: 10.1186/1471-2334-13-127.

10.

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks.

Anekthananon T, Pukrittayakamee S, Ratanasuwan W, Jittamala P, Werarak P, Charunwatthana P, Suwanagool S, Lawpoolsri S, Stepniewska K, Sapchookul P, Puthavathana P, Fukuda C, Lindegardh N, Tarning J, White NJ, Day N, Taylor WR.

J Antimicrob Chemother. 2013 Mar;68(3):697-707. doi: 10.1093/jac/dks418. Epub 2012 Nov 9. Erratum in: J Antimicrob Chemother. 2013 Jul;68(7):1695. Pukritayakamee, S [corrected to Pukrittayakamee, S].

11.

Clinical differences between influenza A (H1N1) virus and respiratory infection between the two waves in 2009 and 2010.

Zarogoulidis P, Glaros D, Kioumis I, Terzi E, Porpodis K, Tsiotsios A, Kallianos A, Trakada G, Machairiotis N, Stylianaki A, Sakas A, Rapti A, Courcoutsakis N, Constantinidis TC, Maltezos E, Zarogoulidis K.

Int J Gen Med. 2012;5:675-82. doi: 10.2147/IJGM.S34940. Epub 2012 Aug 13.

12.

Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.

Wong DD, Choy KT, Chan RW, Sia SF, Chiu HP, Cheung PP, Chan MC, Peiris JS, Yen HL.

J Virol. 2012 Oct;86(19):10558-70. doi: 10.1128/JVI.00985-12. Epub 2012 Jul 18.

13.

Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.

Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, Dwyer DE, Wang B, Smith DW, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D, Barr IG.

J Infect Dis. 2012 Jul 15;206(2):148-57. doi: 10.1093/infdis/jis337. Epub 2012 May 4.

14.

Two years after pandemic influenza A/2009/H1N1: what have we learned?

Cheng VC, To KK, Tse H, Hung IF, Yuen KY.

Clin Microbiol Rev. 2012 Apr;25(2):223-63. doi: 10.1128/CMR.05012-11. Review.

15.

Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections.

Zarogoulidis P, Glaros D, Kontakiotis T, Froudarakis M, Kioumis I, Kouroumichakis I, Tsiotsios A, Kallianos A, Steiropoulos P, Porpodis K, Nena E, Papakosta D, Rapti A, Constantinidis TC, Kerenidi T, Panopoulou M, Trakada G, Courcoutsakis N, Fouka E, Zarogoulidis K, Maltezos E.

Int J Gen Med. 2012;5:175-82. doi: 10.2147/IJGM.S28454. Epub 2012 Mar 5.

16.

The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.

Wu WL, Lau SY, Chen Y, Wang G, Mok BW, Wen X, Wang P, Song W, Lin T, Chan KH, Yuen KY, Chen H.

Antiviral Res. 2012 Jan;93(1):144-53. doi: 10.1016/j.antiviral.2011.11.006. Epub 2011 Nov 25.

17.

Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients.

Martin-Loeches I, Díaz E, Vidaur L, Torres A, Laborda C, Granada R, Bonastre J, Martín M, Insausti J, Arenzana A, Guerrero JE, Navarrete I, Bermejo-Martin J, Suarez D, Rodriguez A; H1N1 SEMICYUC/REIPI/CIBERES Working group.

Crit Care. 2011;15(6):R286. doi: 10.1186/cc10573. Epub 2011 Nov 28.

18.

Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010.

Calatayud L, Lackenby A, Reynolds A, McMenamin J, Phin NF, Zambon M, Pebody R.

Emerg Infect Dis. 2011 Oct;17(10):1807-15. doi: 10.3201/eid1710.110117.

19.

Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis.

Duan S, Boltz DA, Li J, Oshansky CM, Marjuki H, Barman S, Webby RJ, Webster RG, Govorkova EA.

Antimicrob Agents Chemother. 2011 Oct;55(10):4718-27. doi: 10.1128/AAC.00316-11. Epub 2011 Jul 5.

20.

Long-term respiratory follow-up of H1N1 infection.

Zarogoulidis P, Kouliatsis G, Papanas N, Spyratos D, Constantinidis TC, Kouroumichakis I, Steiropoulos P, Mabroudi M, Matthaios D, Kerenidi T, Courcoutsakis N, Zarogoulidis K, Maltezos E.

Virol J. 2011 Jun 25;8:319. doi: 10.1186/1743-422X-8-319.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk